MEREDITH WILLIAMS: Open Payments
NPI 1194717900 · LOVELAND, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,907 in 101 payments from 19 companies in 2025. Trend: 2023 $1,344 · 2024 $1,756 · 2025 $1,907
Food & beverage: $1,907
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 13 | $287 |
| Novartis Pharmaceuticals Corporation | 12 | $185 |
| ABBVIE INC. | 12 | $167 |
| E.R. Squibb & Sons, L.L.C. | 11 | $155 |
| Regeneron Healthcare Solutions, Inc. | 6 | $154 |
| GENZYME CORPORATION | 6 | $152 |
| PFIZER INC. | 13 | $147 |
| Amgen Inc. | 2 | $132 |
| Incyte Corporation | 4 | $77 |
| Lilly USA, LLC | 3 | $70 |
Products named: DUPIXENT, Bimzelx, Sotyktu, OTEZLA, CIBINQO, COSENTYX, SKYRIZI, OPZELURA.
Industry payments across CO — which companies pay providers there.
